World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
13740
World Ranking
16975
National Ranking
6999

Yael P. Mosse publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Yael P. Mosse sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 237 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Yael P. Mosse D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Yael P. Mosse sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 51 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Yael P. Mosse is affiliated with the Children's Hospital of Philadelphia in the United States. Their research primarily spans the fields of medicine, biochemistry, genetics, and molecular biology, with a focused subfield concentration in neurology, molecular biology, cancer research, oncology, and genetics.

Their main topics of work include neuroblastoma research and treatments, cancer, hypoxia, and metabolism, cancer therapeutics and mechanisms, lung cancer research studies, virus-based gene therapy research, ubiquitin and proteasome pathways, as well as lung cancer treatments and mutations.

Frequent co-authors collaborating with Yael P. Mosse are:

  • John M. Maris
  • Kateryna Krytska
  • Julie R. Park
  • Malcolm A. Smith
  • David Groff

Key venues where Yael P. Mosse's research has been published include:

  • Cancer Research
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Clinical Cancer Research
  • Cancer Discovery

Several notable recent papers authored or co-authored by Yael P. Mosse are:

  • The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models (2021), published in Clinical Cancer Research
  • Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912) (2021), published in Clinical Cancer Research
  • Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results (2023), published in Nature Medicine
  • Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium (2021), published in Journal of Clinical Oncology
  • Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers (2021), published in Cancer Research

Best Publications

  • Identification of ALK as a major familial neuroblastoma predisposition gene

    Yaël P. Mossé;Marci Laudenslager;Luca Longo;Kristina A. Cole

  • The genetic landscape of high-risk neuroblastoma

    Trevor J Pugh;Olena Morozova;Edward F Attiyeh;Edward F Attiyeh;Shahab Asgharzadeh;Shahab Asgharzadeh

  • Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

    Yael P Mossé;Megan S Lim;Stephan D Voss;Keith Wilner

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

    Orit Rozenblatt-Rosen;Aviv Regev;Aviv Regev;Aviv Regev;Philipp Oberdoerffer;Tal Nawy

  • Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

    Yael P. Mossé;Stephan D. Voss;Megan S. Lim;Delphine Rolland

  • ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

    Scott C. Bresler;Daniel A. Weiser;Daniel A. Weiser;Peter J. Huwe;Jin H. Park

  • A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene

    Kristina A. Cole;Edward F. Attiyeh;Yael P. Mosse;Michael J. Laquaglia

  • Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

    Mario Capasso;Marcella Devoto;Cuiping Hou;Shahab Asgharzadeh

  • Integrative genomics identifies LMO1 as a neuroblastoma oncogene

    Kai Wang;Kai Wang;Sharon J. Diskin;Haitao Zhang;Edward F. Attiyeh

  • Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma

    John M. Maris;Yael P. Mosse;Jonathan P. Bradfield;Cuiping Hou

  • RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

    Kristina A. Cole;Jonathan Huggins;Michael Laquaglia;Chase E. Hulderman

  • Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma

    Scott C. Bresler;Andrew C. Wood;Andrew C. Wood;Elizabeth A. Haglund;Elizabeth A. Haglund;Joshua Courtright;Joshua Courtright

  • Inhibition of ALK signaling for cancer therapy.

    Yael P. Mossé;Andrew Wood;John M. Maris

  • Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

    Qun Wang;Sharon Diskin;Eric Rappaport;Edward Attiyeh

  • STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments

    Sharon J. Diskin;Thomas Eck;Joel Greshock;Yael P. Mosse

  • Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci

    Lễ B. Nguyễn;Lễ B. Nguyễn;Sharon J. Diskin;Mario Capasso;Kai Wang

  • Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

    Junne Kamihara;Franck Bourdeaut;William D. Foulkes;Jan J. Molenaar

  • Targeting ALK in neuroblastoma—preclinical and clinical advancements

    Erica L. Carpenter;Yael P. Mossé

  • Prevalence and functional consequence of PHOX2B mutations in neuroblastoma

    E H Raabe;M Laudenslager;C Winter;N Wasserman

Frequent Co-Authors

John M. Maris
John M. Maris Children's Hospital of Philadelphia
Hakon Hakonarson
Hakon Hakonarson Children's Hospital of Philadelphia
Malcolm A. Smith
Malcolm A. Smith National Institutes of Health
Wendy B. London
Wendy B. London Harvard University
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
Mark A. Lemmon
Mark A. Lemmon Yale University
Michael D. Hogarty
Michael D. Hogarty Children's Hospital of Philadelphia
Marcella Devoto
Marcella Devoto University of Pennsylvania
Peter C. Adamson
Peter C. Adamson Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're studying Biology or Biochemistry, there are several emerging online degrees and career opportunities worth considering. The demand for professionals in medical coding and billing is on the rise, offering strong job security. Those curious about what is medical coding salary can expect a competitive income, especially with experience and certifications.

Wondering is medical coding a good career? Many find it appealing due to its remote work options, flexibility, and key role in healthcare data management. For those looking to advance in health information systems, there are reputable health information management schools online that provide affordable pathways to this in-demand career.

Additionally, nutrition is a popular field among Biology graduates. If you are interested in deepening your expertise in wellness and dietetics, consider pursuing an online masters degree in nutrition for greater career flexibility and advancement.

Best Scientists Citing Yael P. Mosse

Trending Scientists

Recently Published Articles